Tumor FDG uptake as biomarker for defining the optimal biological dose of the mTOR inhibitor everolimus

Claudia Kuntner (Speaker), D Cejka, Thomas Wanek, M Zsebedics, M Müller, V Wacheck, Oliver Langer

Research output: Chapter in Book or Conference Proceedings › Conference Proceedings with Oral Presentation

Original language	English
Title of host publication	Supplement to Journal of Nuclear Medicine
Pages	118
Number of pages	1
Publication status	Published - 2009
Event	2009 Society of Nuclear Medicine Annual Meeting - Duration: 13 Jun 2009 → 17 Jun 2009

Conference	2009 Society of Nuclear Medicine Annual Meeting
Period	13/06/09 → 17/06/09

Research Field

@inproceedings{d2e5ccd4d9bf49eaac0125dd16622d7f,

title = "Tumor FDG uptake as biomarker for defining the optimal biological dose of the mTOR inhibitor everolimus",

author = "Claudia Kuntner and D Cejka and Thomas Wanek and M Zsebedics and M M{\"u}ller and V Wacheck and Oliver Langer",

year = "2009",

language = "English",

pages = "118",

booktitle = "Supplement to Journal of Nuclear Medicine",

note = "2009 Society of Nuclear Medicine Annual Meeting ; Conference date: 13-06-2009 Through 17-06-2009",

}

TY - GEN

T1 - Tumor FDG uptake as biomarker for defining the optimal biological dose of the mTOR inhibitor everolimus

AU - Cejka, D

AU - Wanek, Thomas

AU - Zsebedics, M

AU - Müller, M

AU - Wacheck, V

AU - Langer, Oliver

A2 - Kuntner, Claudia

PY - 2009

Y1 - 2009

M3 - Conference Proceedings with Oral Presentation

SP - 118

BT - Supplement to Journal of Nuclear Medicine

T2 - 2009 Society of Nuclear Medicine Annual Meeting

Y2 - 13 June 2009 through 17 June 2009

ER -